SCHEMBL30854907

SCHEMBL30854907

CC(=O)C(O)C(c1ccccc1)c1c(O)c2ccccc2oc1=O

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 6/20 0.67
CYP2C9 P11712 8/20 0.65
VKORC1 Q9BQB6 3/20 0.65
ALB P02768 2/20 0.65
HSD17B10 Q99714 2/20 0.65
KDM4E B2RXH2 1/20 0.65
ALDH1A1 P00352 1/20 0.65
PCSK7 Q16549 1/20 0.65
MEN1 O00255 1/20 0.65
KMT2A Q03164 1/20 0.65
TOP1 P11387 1/20 0.60
CRHBP P24387 1/20 0.57
CASP7 P55210 1/20 0.57
CASP6 P55212 1/20 0.57
CRHR2 Q13324 1/20 0.57
HIF1A Q16665 1/20 0.57
CYP3A4 P08684 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7355322 0.84 VKORC1 (0.74) NQO1CYP2C9VKORC1ALBHSD17B10
SCHEMBL10338525 0.83 CYP2C9 (0.70) NQO1CYP2C9VKORC1ALBHSD17B10
SCHEMBL7896856 0.81 NQO1 (1.00) NQO1CYP2C9VKORC1KDM4EALDH1A1
SCHEMBL7355113 0.81 NQO1 (0.94) NQO1CYP2C9VKORC1KDM4EALDH1A1
SCHEMBL18126686 0.80 NQO1 (0.78) NQO1CYP2C9VKORC1MEN1KMT2A
SCHEMBL7352926 0.80 NQO1 (0.69) NQO1CYP2C9VKORC1ALBHSD17B10
SCHEMBL14172134 0.79 NQO1 (0.68) NQO1CYP2C9VKORC1MEN1KMT2A
SCHEMBL14172135 0.79 NQO1 (0.72) NQO1CYP2C9VKORC1ALBHSD17B10
Warfarin SCHEMBL3689 0.79 CYP2C9 (1.00) NQO1CYP2C9VKORC1ALBHSD17B10
Warfarin SCHEMBL662875 0.79 CYP2C9 (1.00) NQO1CYP2C9VKORC1ALBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263774-A1 DISCOVERING NEW XENOBIOTIC SUBSTRATES OF AN UDP-GLYCOSYLTRANSFERASE WITH A HIGH-THROUGHPUT METHOD UNIV NORTH TEXAS (US) 2025-08-21 US disclosed
WO-2024072778-A1 METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS AMYLYX PHARMACEUTICALS, INC. (US) 2024-04-04 WO disclosed